Alterations of MRNAs and Non-coding RNAs Associated with Neuroinflammation in Alzheimer's Disease
Overview
Authors
Affiliations
Alzheimer's disease is a neurodegenerative pathology whose pathognomonic hallmarks are increased generation of β-amyloid (Aβ) peptide, production of hyperphosphorylated (pTau), and neuroinflammation. The last is an alteration closely related to the progression of AD and although it is present in multiple neurodegenerative diseases, the pathophysiological events that characterize neuroinflammatory processes vary depending on the disease. In this article, we focus on mRNA and non-coding RNA alterations as part of the pathophysiological events characteristic of neuroinflammation in AD and the influence of these alterations on the course of the disease through interaction with multiple RNAs related to the generation of Aβ, pTau, and neuroinflammation itself.
Recent advances of PIWI-interacting RNA in cardiovascular diseases.
Li B, Wang K, Cheng W, Fang B, Li Y, Yang S Clin Transl Med. 2024; 14(8):e1770.
PMID: 39083321 PMC: 11290350. DOI: 10.1002/ctm2.1770.
Wang Y, Yang Y, Liang C, Zhang H Int J Mol Sci. 2024; 25(13).
PMID: 39000042 PMC: 11241202. DOI: 10.3390/ijms25136934.
Almohaimeed H, Almars A, Alsulaimani F, Basri A, Althobaiti N, Albalaw A Front Aging Neurosci. 2024; 16:1379431.
PMID: 38867846 PMC: 11168113. DOI: 10.3389/fnagi.2024.1379431.